Suchergebnisse - "Gourzoulidis, George"

PubPharm (47)

1

Lorlatinib as a first-line treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer : Α cost-effectiveness analysis in Greece

enthalten in: Expert review of pharmacoeconomics & outcomes research | 2024

von Gourzoulidis, G. | Zisimopoulou, O. | Liavas, A. | +1

2

Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece

enthalten in: Clinical drug investigation | 2024

von Gourzoulidis, G. | Solakidi, A. | Psarra, M. | +2

3

Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece

enthalten in: Clinical drug investigation | 2023

von Gourzoulidis, G. | Solakidi, A. | Psarra, M. | +2

4

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants

enthalten in: Vaccines | 2023

von Warren, S. | Barmpouni, M. | Kossyvaki, V. | +2

5

Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece

enthalten in: Value in health regional issues | 2023

von Tzanetakos, C. | Gourzoulidis, G.

6

EFOMP policy statement 17 : The role and competences of medical physicists and medical physics experts in the different stages of a medical device life cycle

enthalten in: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) | 2023

von van Asten, W. | Markidou, E. | Gromoll, C. | +7

7

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece

enthalten in: Frontiers in public health | 2023

von Gourzoulidis, G. | Barmpouni, M. | Kossyvaki, V. | +2

8

Correction to : Cost‑Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece

enthalten in: Clinical drug investigation | 2023

von Gourzoulidis, G. | Koulentaki, M. | Kattamis, A. | +5

ErratumFor: Clin Drug Investig. 2022 Nov;42(11):999-1008. - PMID 36227415

9

Correction to: Cost‑Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece

enthalten in: Clinical drug investigation | 2022

von Gourzoulidis, G. | Koulentaki, M. | Kattamis, A. | +5

10

Correction to: Cost‑Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece

enthalten in: Clinical drug investigation | 2022

von Gourzoulidis, G. | Koulentaki, M. | Kattamis, A. | +5

1
2
3
4
5
Nächster »
[5]